FDA Announces Public Advisory Committee Meeting on Cellular, Tissue and Gene Therapies

Summary

The FDA is hosting a public advisory committee meeting of the Cellular, Tissue and Gene Therapies Advisory Committee to provide advice on FDA's regulatory issues, with at least one portion closed to the public.